Associate Professor Richard Young
NHMRC Externally-Funded Research Fellow (D)
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
A/Prof Richard L Young is a Senior Research Fellow in the Adelaide Medical School at The University of Adelaide, and the South Australian Health & Medical Research Institute (SAHMRI). He is a member of the Centre of Research Excellence in Translating Nutritional Science to Good Health, which links basic and clinician researchers in world-leading research in diabetes.
A/Prof Young heads the Intestinal Sensing Group within the Nutrition, Diabetes and Gut Health Program of SAHMRI Lifelong Health. He investigates the intestinal taste system, which detects dietary sugars and low-calorie sweeteners and, in turn, controls how glucose is absorbed and disposed in the body. He has shown how this system is regulated in health, and its dysregulation in type 2 diabetes, critical illness and obesity. This NHMRC supported research is providing new knowledge of gut physiology and microbiology, with the potential to prevent, and better manage, type 2 diabetes and obesity.
We offer higher degree research projects that span interventional clinical research through to basic research with genetic and disease models. These projects aim to find new ways to treat diabetes and save lives in critical illness and can be tailored to the individual student. One-year Honours projects are also available in these areas. Students will be based in the west-end health precinct in SAHMRI, with clinical studies undertaken in the University of Adelaide AHMS building (Clinical Research Facility, CRF).
- Can blocking gut sweet sensing improve blood glucose control in type 2 diabetes? We've discovered that habitual high intake of low-calorie sweeteners can worsen control of blood glucose in healthy subjects. Individuals with type 2 diabetes may be at even higher risk due an existing defect in sweet sensing in their gut. This project will investigate whether blocking sweet sensing in the gut improves control of blood glucose in type 2 diabetes. This project will involve clinical research in the University of Adelaide CRF and laboratory experiments in SAHMRI, in an effort to discover new ways to treat diabetes. Project start: Semester 1 and 2.
- How does the human gut respond to sweet and bitter stimuli? This project will establish the precise mechanisms that link sensing of bitter and sweet (e.g., low-calorie sweeteners) in the gut wall and gut bacteria to signals that disrupt host control of blood glucose. This will involve functional and multiomic experiments in human biopsy tissues and experiments examining gut bacteria in SAHMRI. Project start: Semester 1 and 2.
- Saving lives in critical illness by preserving cortisol targeting Blood levels of the carrier protein for cortisol fall in many patients with sepsis in a manner that predicts their death. Supplementing this protein in these patients may preserve its unique capacity to deliver the full benefits of cortisol's anti-inflammatory actions to injured tissues. Using our mouse model, which responds to sepsis in the same manner as patients, we aim to provide fundamental knowledge on the value of novel therapies to save lives. This is an exciting space and has the promise to deliver the first new therapy for sepsis management in decades. This project will involve clinical research in the University of Adelaide CRF and laboratory experiments in SAHMRI. Project start: Semester 1 and 2.
-
Appointments
Date Position Institution name 2016 - ongoing Associate Professor The University of Adelaide -
Education
Date Institution name Country Title University of Melbourne, Melbourne Australia PhD University of Adelaide, Adelaide Australia BSc Honours University of Adelaide, Adelaide Australia BSc -
Research Interests
-
Journals
-
Book Chapters
Year Citation 2019 Martin, A. M., Young, R. L., Leong, L., Rogers, G. B., Spencer, N. J., Jessup, C. F., & Keating, D. J. (2019). Cellular regulation of peripheral serotonin. In P. M. Pilowsky (Ed.), Serotonin: The Mediator that Spans Evolution (pp. 137-153). London, United Kingdom: Academic Press.
DOI Scopus6 -
Conference Papers
Year Citation 2018 Nam, Q. N., Naidu, J., Debricini, T., Burgess, J., Safaeian, R., Young, R., & Horowitz, M. (2018). Is dysregulation of intestinal glucose transporters in the morbidly obese responsible for the development of diabetes mellitus?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 218-219). WILEY. 2014 Nguyen, N. Q., Debreceni, T. L., Bambrick, J. E., Chia, B., Wishart, J. M., Deane, A. M., . . . Young, R. L. (2014). Accelerated Glucose Absorption in Proximal Intestine and Its Relationship to Glucose Transporters, Incretin Hormones and Glycaemia in Morbidly Obese Humans: the "X-Factor" of the Foregut Theory?. In GASTROENTEROLOGY Vol. 146 (pp. S108). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2014 Nguyen, N. Q., Debreceni, T. L., Bambrick, J. E., Chia, B., Wishart, J. M., Wittert, G. A., . . . Young, R. L. (2014). Impact of a 2-Week Very Low Calorie Diet (VLCD) on Glucose Sensing, Absorption, Transporters, Incretin Hormones and Glycemia in Morbidly Obese Humans. In GASTROENTEROLOGY Vol. 146 (pp. S899). IL, Chicago: W B SAUNDERS CO-ELSEVIER INC. 2013 Nguyen, N. Q., Debreceni, T. L., Chia, B., Burgstad, C. M., Neo, M., Wittert, G. A., . . . Young, R. L. (2013). Alterations in the Expression of Intestinal Sweet Taste Receptor and Glucose Transporters After Roux-en-Y Gastric Bypass: An Adaptive Response to Prevent Carbohydrate Malabsorption. In GASTROENTEROLOGY Vol. 144 (pp. S64). FL, Orlando: W B SAUNDERS CO-ELSEVIER INC. 2013 Nguyen, N. Q., Debreceni, T. L., Chia, B., Burgstad, C. M., Neo, M., Deane, A. M., . . . Young, R. L. (2013). Intestinal Sweet Taste Receptor and Transporter Expression, Post-Prandial Glycemia and Glucose Absorption in Morbidly Obese Subjects. In GASTROENTEROLOGY Vol. 144 (pp. S836). Orlando, FL: W B SAUNDERS CO-ELSEVIER INC. 2013 Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, A., Nguyen, N. Q., . . . Brierley, S. M. (2013). Alterations in the Guanylate Cyclase-C/cGMP Pathway in Patients With Irritable Bowel Syndrome With Constipation. In GASTROENTEROLOGY Vol. 144 (pp. S59-S60). Orlando, FL: W B SAUNDERS CO-ELSEVIER INC. 2011 Young, R. L., Chia, B., Ma, J., Wu, T., Khoo, J., Horowitz, M., . . . Rayner, C. (2011). Disordered Control of Intestinal Sweet Taste Receptor Expression in Type 2 Diabetes. In GASTROENTEROLOGY Vol. 140 (pp. S99-S100). IL, Chicago: W B SAUNDERS CO-ELSEVIER INC. 2011 Young, R. L., Deane, A. M., Chia, B., Horowitz, M., Blackshaw, L. A., & Rayner, C. (2011). Dysregulation of Intestinal Glucose Transporter and Sweet Taste Receptor Expression in Critical Illness. In GASTROENTEROLOGY Vol. 140 (pp. S194). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2011 Little, T., Young, R., Blackshaw, L., Rayner, C., & Feinle-Bisset, C. (2011). Expression of the fatty acid sensors, CD36, GPR119 and GPR120, in the duodenum of humans. Relationships with obesity. In 19th Annual Meeting of the Society for the Study of Ingestive Behavior Vol. 575 (pp. S26). Netherlands: Elsevier BV.
DOI2011 Wu, T., Zhao, B., Bound, M., Checklin, H. L., Bellon, M., Little, T. J., . . . Rayner, C. K. (2011). Effects of different sweet preloads on incretin hormone responses, gastric emptying and postprandial glycaemia in healthy humans. In DIABETOLOGIA Vol. 54 (pp. S330). Lisbon, PORTUGAL: SPRINGER. 2010 Harrington, A., Young, R., Brierley, S., & Blackshaw, L. (2010). TRPV1 mediates acid activation of esophageal sensory pathways. In Proceedings of 2010 Joint International Neurogastroenterology and Motility Meeting, NGM 2010 Vol. 22 (pp. 55). UK: Wiley-Blackwell Publishing Ltd. 2008 Sutherland, K., Brierley, S. M., Rayner, C., Horowitz, M., Blackshaw, L. A., & Young, R. L. (2008). Altered duodenal sweet taste receptor expression in diabetic hyperglycemia. In GASTROENTEROLOGY Vol. 134 (pp. A44). W B SAUNDERS CO-ELSEVIER INC. 2007 Sutherland, K., Brierley, S. M., Horowitz, M., Rayner, C., Blackshaw, L. A., & Young, R. L. (2007). Sweet taste transduction molecules are expressed in the upper gastrointestinal tract in humans. In GASTROENTEROLOGY Vol. 132 (pp. A587). Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
WoS32007 Pezos, N., Sutherland, K., Brierley, S. M., Horowitz, M., Blackshaw, L. A., & Young, R. L. (2007). Vagal afferents do not directly detect intestinal glucose via a sweet-taste mechanism. In GASTROENTEROLOGY Vol. 132 (pp. A587). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2006 Sutherland, K., Cooper, N. J., Horowitz, M., Margolskee, R. F., Blackshaw, L. A., & Young, R. L. (2006). Taste receptor G-protein α-gustducin does not colocalise with enteroendocrine cell markers in the mouse intestine. In GASTROENTEROLOGY Vol. 130 (pp. A605). Los Angeles, CA: W B SAUNDERS CO-ELSEVIER INC. 2005 Gountounas, N., Cooper, N. J., Horowitz, M., Margolskee, R. F., Blackshaw, L. A., & Young, R. L. (2005). Does the gut 'taste' sweet? Identifying glucosensor molecules in the small intestine. In GASTROENTEROLOGY Vol. 128 (pp. A555). Chicago, IL: W B SAUNDERS CO. 2002 Young, R. L., Cooper, N. J., & Blackshaw, L. A. (2002). Neurochemical coding of gastric vago-vagal pathways in the ferret. In JOURNAL OF PHYSIOLOGY-LONDON Vol. 543 (pp. 5P). UNIV LIVERPOOL, LIVERPOOL, ENGLAND: CAMBRIDGE UNIV PRESS. -
Conference Items
NHMRC (last 5 years)
- 2023-26 Ideas (APP2019948) ‘Harnessing a native corticosteroid-binding globulin to treat life-threatening septic shock’. Young RL, Torpy DJ, Nenke MA. AI: Meyer EJ, Plummer MP, Ahamed M.
- 2023-26 Ideas (APP2020454) ‘Stratifying low-calorie sweeteners for diabetes risk’. Rayner CK, Rogers GB. AI: Young RL, Ivey KL, Snel MF, Miller CL, Wu T, Lange K.
- 2021-23 Ideas (APP2001271) ‘Characterisation of erusiolin - a new peptide hormone’ Larance M, Hocking S. AI: Young RL, Solon-Biet SM, Neely GG, Samocha-Bonet D, Viardot A, Payne RJ.
- 2020-23 Ideas (APP1181145) Young RL, Ivey KL. AI: Miller CL, Rayner CK, Keating DJ, Lynn DJ, Rogers, GB, Snel MF, Horowitz M. 'Friend or Foe? Low-calorie sweeteners and glycaemic control in type 2 diabetes'
- 2019-21 Project (APP1164475) Keating DJ, Young RL, Holst JJ, Knop FK. 'Targeting proglucagon cells in the human gut to treat diabetes and obesity.'
- 2018-20 Project (APP1147333) Wu T, Rayner CK, Jones KL, Young RL, Feinle-Bisset C. 'Bitter taste as a mediator of food intake and postprandial glycaemia in health and type 2 diabetes'
Diabetes Australia (last 5 years)
- 2023 Project 'Targeting intestinal bile acid sensing mechanisms to manage type 2 diabetes.' Wu T, Rayner CK, Horowitz M, Young RL, Xie C, Jones KL.
- 2023 Project 'Impact of renal 'sweet taste' sensing on the risk of dysglycaemia.' Rayner CK, Wu T, Young RL, Thomas MC, Xie C, Huang W.
- 2022 Project 'Host or the hosted? Mechanisms underlying intestinal control of glycaemia in type 2 diabetes'. Young RL, Rayner CK, Horowitz M, Wu T, Rogers GB, Ivey KL.
- 2021 Project 'Blocking intestinal sweet taste for glycaemic benefits in type 2 diabetes.' Young RL, Rayner CK, Horowitz M, Wu T, Rogers GB, Ivey KL.
- 2021 Project 'More or less? Bile acids and glycaemic control in type 2 diabetes. Wu T, Rayner CK, Jones KL, Young RL, Horowitz M.
- 2020 Project 'Does the gut microbiome link intake of low-calorie sweeteners to impaired blood glucose control?' Young RL, Rogers GB, Rayner CK, Horowitz M, Wu T.
- 2018-19 Millennium Award, Type 2 Diabetes. 'Do artificial sweeteners affect glycaemic control adversely in people with type 2 diabetes?' Rayner CK, Young RL, Horowitz M, Wu T.
Diabetes UK (last 5 years)
- 2024-7 Project Grant. Identifying the mechanisms of gut–brain axis to sweet sensing in patients with type 2 diabetes using neuroimaging techniques. Eldeghaidy S, Yang Q, Idris I (Nottingham University), Young RL, Page AJ.
The Hospital Research Foundation (last 5 years)
- 2018-20 Translational Research 'A bitter tale of artificial sweeteners in Type 2 diabetes?' Young RL, Rayner CK, Rogers GB.
Diabetes SA (last 5 years)
- 2022-23 (Project) 'Blocking intestinal sweet taste for better glycaemic control in type 2 diabetes.' Young RL, Rayner CK, Rogers GB, Horowitz M.
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2023 Principal Supervisor Harnessing a native corticosteroid-binding globulin to treat life-threatening septic shock Master of Clinical Science Master Part Time Mr Benjamin James Young -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2020 - 2024 Co-Supervisor Adaptations of small intestinal nutrient absorption during pregnancy in mice Doctor of Philosophy Doctorate Full Time Mr Teunis Sebastian Overduin 2020 - 2024 Principal Supervisor Glycaemic consequences of non-nutritive sweeteners in human health and type 2 diabetes Doctor of Philosophy Doctorate Full Time Mr Braden David Rose 2019 - 2023 Principal Supervisor Gut mechanisms linking low-calorie sweeteners to impaired glycaemic control Doctor of Philosophy Doctorate Part Time Miss Denise Kreuch 2012 - 2017 Principal Supervisor Gastrointestinal Nutrient Sensing in Obesity and type 2 Diabetes: Role in Appetite Regulation and Glycaemic Control Doctor of Philosophy Doctorate Full Time Ms Nada Cvijanovic 2004 - 2009 Co-Supervisor Nutrient Sensing Mechanisms in the Small Intestine: Localisation of Taste Molecules in Mice and Humans With and Without Diabetes Doctor of Philosophy Doctorate Full Time Ms Kate Sutherland -
Other Supervision Activities
Date Role Research Topic Location Program Supervision Type Student Load Student Name 2014 - ongoing External Supervisor Isolation, purification and characterisation of human enteroendocrine cells Flinders University of South Australia School of Medicine, PhD Doctorate Full Time Emily Wai-Ling Sun
Connect With Me
External Profiles